Arctic Bioscience AS (OSL:ABS) ROE % Adjusted to Book Value : -17.81% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS ROE % Adjusted to Book Value?

Arctic Bioscience AS's ROE % for the quarter that ended in Dec. 2023 was -18.34%. Arctic Bioscience AS's PB Ratio for the quarter that ended in Dec. 2023 was 1.03. Arctic Bioscience AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -17.81%.

Arctic Bioscience AS ROE % Adjusted to Book Value Historical Data

The historical data trend for Arctic Bioscience AS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS ROE % Adjusted to Book Value Chart

Arctic Bioscience AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-16.41

-11.20

-16.19

Arctic Bioscience AS Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial					-9.51	-8.92	-12.86	-16.09	-17.81

Competitive Comparison of Arctic Bioscience AS's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Arctic Bioscience AS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arctic Bioscience AS's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arctic Bioscience AS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Arctic Bioscience AS's ROE % Adjusted to Book Value falls into.

Arctic Bioscience AS ROE % Adjusted to Book Value Calculation

Arctic Bioscience AS's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-16.68%	/	1.03
	=	-16.19%

Arctic Bioscience AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-18.34%	/	1.03
	=	-17.81%

Arctic Bioscience AS ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Arctic Bioscience AS's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Arctic Bioscience AS (OSL:ABS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Industrivegen 42, Orsta, NOR, 6155

Website

https://www.arctic-bioscience.com

Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand.

Arctic Bioscience AS (OSL:ABS) Headlines

No Headlines